Physician profile
Adi Akerman
NPI 1093196867
$3,569.43
in general payments reported to CMS, 2019-2025
22 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $653 · 2020: $71.29 · 2021: $284 · 2022: $1,431 · 2023: $355 · 2024: $625 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,130.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,584.16 | 2022-2025 | |
| Stryker Corporation | $536.83 | 2019-2023 | Augment Injectable |
| Bone Support INC. | $292.59 | 2021-2024 | Ceramentbone Void Filler, Cerament G |
| Integra Lifesciences Corporation | $207.58 | 2019-2025 | Cytal |
| Paragon 28, INC. | $179.73 | 2019-2024 | Bun-Yo-Matic |
| Biocomposites INC | $142.89 | 2024 | |
| Carbofix Orthopedics INC | $103.00 | 2022 | |
| Tei Medical INC. | $94.11 | 2019 | |
| Smith+Nephew, INC. | $84.08 | 2020-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Renasys Go V2 Home |
| Anika Therapeutics, INC. | $72.43 | 2024 | Integrity, Tactoset, Toe Motion |
| Abbott Laboratories | $62.68 | 2023-2024 | Proclaim, Eterna |
| Biotissue Holdings INC. | $28.60 | 2024 | |
| Grt US Holding, INC. | $27.04 | 2022 | |
| Alafair Biosciences, INC. | $25.92 | 2022-2023 | Versawrap |
| Nevro Corp. | $23.01 | 2023 | Senza |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $22.47 | 2023 | |
| Innovation Technologies INC | $16.20 | 2024 | Irrisept |
| Paratek Pharmaceuticals, INC. | $16.15 | 2023 | Nuzyra |
| Arthrosurface Incorporated | $15.41 | 2025 | Toe Motiontm |
| Heron Therapeutics, INC. | $14.00 | 2023 | Zynrelef |
| Horizon Therapeutics Plc | $11.49 | 2019 | |
| Kerecis Limited | $9.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adi Akerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.